[Explanation] On February 26, in the workshop of Daxing branch of Beijing Tongrentang (Group) Co., Ltd., workers were producing pills in an orderly manner. According to reports, in order to ensure the supply of medicines for the epidemic, while doing a good job of corporate epidemic prevention and control, the production units of Tongrentang Group have resumed production on January 28. At present, the employment rate of employees in four industrial units in Beijing has exceeded 70%, and some production units have resumed work.
[Concurrent] Di Shubing, General Manager of Tongrentang Group
Our employees must take a temperature test before getting on our shuttle. Before we enter the factory, we need to perform a second inspection. Our daily disinfection is much more frequent than usual, and we have strict requirements when dining. Only one person can sit at a table. Therefore, various measures should be said to be in place.
[Explanation] It is understood that Suhexiang Pills and Zixuesan produced by Tongrentang Group have been officially included in the "Pneumonitis Diagnosis and Treatment Program for New Coronavirus" published by the state. Di Shubing introduced that after the epidemic, some of the drug inventory of Tongrentang Group had a shortage. To this end, Tongrentang Group has urgently adjusted its production plan to ensure adequate supply of key drugs for epidemic prevention and control in various places.
[Concurrent] Di Shubing, General Manager of Tongrentang Group
According to the situation in Wuhan at the time before the holiday, we screened forty-two medicines. We also included Suhexiang pills in one of them, and we adjusted and guaranteed production plans. We have adjusted the production plan for the last three quarters to the first quarter of 2020. So at present, the national market guarantee of our Suhexiang Pills has no problem at all.
[Explanation] Di Shubing introduced that among the more than 500 product approval numbers owned by Tongrentang Group, there are only more than 200 varieties produced all year round, and the rest become "sleeping varieties". Shiyi Qingwen Wan is one of them. In order to fight the epidemic, Tongrentang Group restarted the production of Shiyi Qingwen Pills and has now entered the pill making process.
[Concurrent] Di Shubing, General Manager of Tongrentang Group
Because this medicine is an old medicine in the history of Tongrentang, this medicine has been asleep. We call it the sleep variety. But after our experts demonstrated that this drug should be symptomatic to the symptoms we have seen (new coronary pneumonia), so it was recommended by many experts, so we decided to resume production. Our various procedures have been completed within 22 days, and we expect to be able to produce three batches of 150,000 pills by Friday, hoping to make some contributions to society.
Reported by Wang Shibo in Beijing
Editor-in-chief: [Liu Xian]